These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 32766169)

  • 21. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis.
    Zheng Y; Ding Q; Wei Y; Gou X; Tian J; Li M; Tong X
    Phytomedicine; 2021 Jul; 88():153455. PubMed ID: 33478831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omega-3 Fatty Acids and Their Interaction with the Gut Microbiome in the Prevention and Amelioration of Type-2 Diabetes.
    Kumar M; Pal N; Sharma P; Kumawat M; Sarma DK; Nabi B; Verma V; Tiwari RR; Shubham S; Arjmandi B; Nagpal R
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
    Duan L; An X; Zhang Y; Jin D; Zhao S; Zhou R; Duan Y; Zhang Y; Liu X; Lian F
    Biomed Pharmacother; 2021 Oct; 142():112094. PubMed ID: 34449321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites.
    Zhang X; Wang H; Xie C; Hu Z; Zhang Y; Peng S; He Y; Kang J; Gao H; Yuan H; Liu Y; Fan G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1194():123189. PubMed ID: 35219959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Gut Microbiota by Herbal Medicines.
    Shinde Y; Deokar G
    Curr Drug Metab; 2024; 25(2):110-127. PubMed ID: 38571357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.
    Tian R; Liu H; Feng S; Wang H; Wang Y; Wang Y; Liang L; Xu H; Xing H; Zhang S
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1454-1466. PubMed ID: 33810955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gut microbiota in type 1 diabetes: friend or foe?
    Gavin PG; Hamilton-Williams EE
    Curr Opin Endocrinol Diabetes Obes; 2019 Aug; 26(4):207-212. PubMed ID: 31145129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise for the Diabetic Gut-Potential Health Effects and Underlying Mechanisms.
    Valder S; Brinkmann C
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury.
    Li Y; Zhang Y; Wei K; He J; Ding N; Hua J; Zhou T; Niu F; Zhou G; Shi T; Zhang L; Liu Y
    Front Cell Infect Microbiol; 2021; 11():577236. PubMed ID: 34307184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiota and Their Associated Metabolites in Diabetes: A Cross Talk Between Host and Microbes-A Review.
    Safari-Alighiarloo N; Emami Z; Rezaei-Tavirani M; Alaei-Shahmiri F; Razavi S
    Metab Syndr Relat Disord; 2023 Feb; 21(1):3-15. PubMed ID: 36301254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the microbiome in the management of children with type 2 diabetes mellitus.
    Brar PC; Kohn B
    Curr Opin Pediatr; 2019 Aug; 31(4):524-530. PubMed ID: 31299021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulating the Gut Microbiota and Metabolites with Traditional Chinese Medicines: An Emerging Therapy for Type 2 Diabetes Mellitus and Its Complications.
    Jiang P; Di Z; Huang W; Xie L
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
    Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
    Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
    Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
    mBio; 2018 May; 9(3):. PubMed ID: 29789365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.